Deadline for submission of 1) application and 2) supporting
documents: February 2, 2018
About these Awards
The International Network
for Orofacial Pain and Related Disorders Methodology (INfORM): A consortium
focused on clinical translational research (hereafter, International Network)
in conjunction with Quintessence Publishing and
Journal of Oral & Facial
Pain and Headache
provides an award for early career clinical
researchers/scientists. The Awards will be given to investigators for an
outstanding clinical or translational research abstract and project pertaining
to Orofacial Pain and Related Conditions submitted to the IADR General Annual
Session & Exhibition.
Definition of clinical and translational research for the purpose of these awards
Applicable clinical research pertains to diagnostic criteria, management guidelines, statistical or design methodology, or findings relevant to any of those categories. Applicable translational research pertains to applied basic or laboratory science that fits within the above categories, but that must clearly demonstrate translation of its findings to the clinic and include future plans for how this will occur. Basic or laboratory science that does not fit within the above requirements is outside the scope of this competition. In short, demonstrating relevance of the research to the mission of the Consortium Network is essential. Those considering applications based on basic or laboratory science pertaining to orofacial pain and related conditions are recommended to first refer to the IADR Neuroscience Group’s Wiley-Blackwell Investigator award description and determine if their research would better fit eligibility criteria for that award and, if so, then the research will not likely fit the criteria for this award. If individuals still have queries about the eligibility of their research after referring to the Neuroscience Group’s award criteria they should contact the chair of the Consortium’s award (insert email address) with a brief abstract (<250words) of their research to ascertain if it is eligible for inclusion in the Consortium network’s competition.
Applying for the award
Potential applicants should note that applications for this award cannot be submitted to other Group or Network competitions at the same IADR annual scientific meeting. Award panels will confer as necessary on entries for the forthcoming meeting.
The Consortium Network and Quintessence Publishing awards consist of two categories:
- IADR-International Network Pre-doctoral Fellow Award. A pre-doctoral student attending a higher academic institution will be eligible to apply for this award. The winner will be awarded with $500 USD and a certificate of award.
- IADR-International Network Post-doctoral Fellow Award. A post-doctoral researcher working within a higher academic institution will be eligible to apply for this award. The winner will be awarded with $1,000 USD and a certificate of award.
Each category will require a minimum of three applicants for the competition to take place. Applicants will be selected by a judging panel nominated by the officers of the IADR International Network and is further described below.
The category for competition is based on applicant status at the time of submission of the application:
- Pre-doctoral applicants must currently be enrolled within an academic institution in a pre-doctoral B.D.S, D.D.S., D.M.D., M.D., or Ph.D. program or other similar degree program.
- Post-doctoral applicants must be within 5 years of graduation of a higher doctoral degree and no longer enrolled in a degree-granting program.
In addition, the following criteria must be met for both categories:
- The applicant may submit his/her abstract for the IADR General Session to any of the research Groups or Networks within the IADR.
- The applicant must not submit the abstract to a competition of another IADR Group or Network.
- IADR membership is required, but Consortium Network membership is NOT a requirement.
- NOT eligible are 1) current officers of the IADR Consortium Network and 2) previous award winners in the same categories.
- Applicants must submit their abstracts to the IADR General Session & Exhibition, and adhere to the normal IADR abstract format. Please visit www.iadr.org/iags for more information.
- Applicants must check the box on the IADR online abstract application form to specifically apply for this Award. This step when you submit your abstract at www.iadr.org/iags is essential in order for your abstract to be considered for this competition.
- In addition to the abstract submission on the IADR web site, applicants must email the following 3 documents to at (email address):
- A one-page biography or CV containing the following information: name, date of birth, undergraduate and postgraduate studies completed, principal investigator or supervisor name, and research publications.
- A one-page letter of recommendation submitted by the principal investigator, supervisor, or the head of the research department at the applicant’s school or university, as determined by whether the applicant is entering the pre- or post-doctoral competition. The letter should provide detail appropriate to the stage of career development of the applicant and that the applicant is the principle researcher of the submitted research abstract.
- A document with a detailed Project (maximum 5 double-spaced A4 or US letter-sized pages at size 12 point Arial font with standard word document page margins [2.54cm superior/inferior, and lateral]) saved as a PDF with the following 6 sections:
Section 1. Abstract (same as submitted through the IADR website);
Section 2. Introduction: literature review, rationale/hypothesis, goal;
Section 3. Methodology: sample collection (if present), randomization procedure (if present), test/control groups (if present), assays, and statistics; sample size and power computations should also be provided, as appropriate, and provide rationale if sample size cannot be calculated;
Section 4. Results: main findings, statistical data;
Section 5. Conclusions: impact/innovation on translational or clinical sciences within the scope of the IADR Consortium Network; and
Section 6. Bibliographic references.
Please note if applicants exceed any of the page specifications or include additional information this additional information will be disregarded and applicants run the risk of being excluded from the competition for non-compliance with the regulations. Applicants will not receive feedback on incorrectly submitted applications. The applicant is responsible for insuring that the application process is correctly followed. Feedback will not be provided to those who do not progress to the final.
- The judging process will be coordinated by the panel Chairperson who will be the President of the Consortium Network or the President’s designee (another Consortium officer).
- The judging panel will be appointed by the panel Chairperson and will be comprised of the following members: Editor-in-Chief of the Journal of Oral & Facial Pain and Headache (or a nominated deputy), the Secretary/Treasurer of the Consortium Network or his/her designee, and three additional officers or senior IADR members of the Consortium Network.
Judging Rules, Principles and Criteria
The judging panel will select a maximum of 6 candidates (nominally, 3 candidates for each award, depending on submissions) as finalists for the main poster competition based on the following rules and principles applied to the submitted written documents:
- Clarity of presentation, scientific strength, relevance, and potential impact.
- Data presented should be original and unpublished.
- Selected candidates will be informed 6-8 weeks after submission deadline.
- At the IADR meeting, applicants are required to present their findings twice: 1) during the designated Award competition session to the judging panel in the form of a poster presentation, and 2) during a regular session (General Session or Exhibit Hall) in the form of an oral or poster presentation, depending on the acceptance of the abstract as oral or poster presentation, and which is not judged for this competition. If the abstract is accepted as an oral presentation, a poster will be created for the competition presentation. If the abstract is accepted as a poster presentation, the same poster should be used for both the competition presentation as well as the regular session presentation. The poster format recommended at www.iadr.org should be followed.
- In the first session with the Award judging panel, the applicants will be called in alphabetical order (by their last name stated in their abstract) to enter a conference room where the Award poster competition will take place.
- Judges will spend 20 minutes at each poster: 10 minutes presentation by the candidates to the judges followed by 10 minutes of questions.
CRITERIA for judging and rating the finalists:
- Novel impact on the field of methodology for clinical translational research in orofacial pain and related disorders.
- Goal of the study and hypothesis is clearly stated.
- Methodology is appropriate to the study goal and hypothesis.
- Innovation on the study design.
- Statistics are appropriately used to analyze the data.
- Conclusions are based on the presented data.
- Well-organized poster presentation (which includes the poster itself and the oral performance).
- Applicant is knowledgeable on the study being presented.
- Adherence to allocated presentation time (10 min.).
The winners of the Award will be invited to attend the IADR International Network business meeting taking place during the IADR General Session, at which the winner will be announced and the award certificate received. The cash Awards will be given at a later date (usually 3-4 weeks after the meeting).
Abstract and supporting documents must be sent no later than the IADR abstract deadline of February 2, 2018 to Chairperson Frank Labbezoo at firstname.lastname@example.org.
* Pending Council approval at the IADR 2018 meeting in London, the new name of the Consortium Network will be “International Network for Orofacial Pain and Related Disorders Methodology (INfORM): A consortium focused on clinical translational research